Sanara MedTech Inc. beneficial ownership disclosure: Baird Trust Company, Baird Financial Corporation and Baird Financial Group, Inc. report aggregated beneficial ownership of 21,075 shares of Common Stock. The filing bases the percentage on 9,167,040 Shares outstanding as of March 20, 2026.
The reporting persons state the shares reflect shared voting and dispositive power held by Baird Trust Company on behalf of clients. Ownership is reported as 5% or less of the class.
Positive
None.
Negative
None.
Insights
Small, passive position reported by Baird entities via voting discretion.
The filing lists 21,075 shares as subject to shared voting and dispositive power by Baird Trust Company, aggregated with parent entities for reporting under Rule 13d-4. The position equals a de minimis percentage of the reported class.
Impact is limited: the disclosure documents custodial/investment-discretion arrangements rather than an active control stake; subsequent filings would show any material change in holdings.
Aggregation and attribution reflect standard Rule 13d-3/13d-4 mechanics.
The Schedule 13G/A aggregates holdings of BTC, BFC, and BFG per Release No. 34-39538 and clarifies parent/subsidiary relationships. It also includes the issuer's outstanding share base used to calculate the percentage.
Watch for later amendments if voting authority or beneficial ownership changes; current disclosure states ownership remains under the 5% threshold.
Key Figures
Aggregated shares reported:21,075 sharesShares outstanding used for percentage:9,167,040 SharesOwnership threshold:5% or less+2 more
5 metrics
Aggregated shares reported21,075 sharesshared voting and dispositive power reported by Baird Trust Company
Shares outstanding used for percentage9,167,040 SharesOutstanding shares as of March 20, 2026 per issuer Form 10-K
Ownership threshold5% or lessItem 5 response: ownership of 5 percent or less of a class
CUSIP79957L100Security identifier on the cover page
Cover date03/31/2026Date shown on the cover page of the Schedule 13G/A amendment
"deemed to beneficially own within the meaning of Rule 13d-3"
Rule 13d-3 defines who is treated as the beneficial owner of a company’s shares for U.S. securities disclosure rules — essentially anyone who has the power to vote or direct how shares are voted, or the power to buy or sell them, even if they don’t hold the certificates. For investors this matters because crossing certain ownership thresholds triggers public filing and disclosure obligations and signals potential control or influence, much like having the keys to a car implies you can drive it even if it’s registered to someone else.
Release No. 34-39538regulatory
"aggregated together in accordance with Release No. 34-39538"
What stake does Baird report in Sanara MedTech (SMTI)?
Baird reports aggregated beneficial ownership of 21,075 shares. The filing aggregates holdings for Baird Trust Company, Baird Financial Corporation, and Baird Financial Group, Inc., showing shared voting and dispositive power.
How was the ownership percentage for SMTI calculated?
The percentage is calculated using 9,167,040 Shares outstanding as of March 20, 2026. The filing states the percentage based on that outstanding share figure from the issuer's Form 10-K.
Does the filing indicate Baird controls SMTI?
No. The filing shows shared voting and dispositive power via Baird Trust Company acting for clients and expressly aggregates holdings without admitting beneficial ownership under Sections 13(d) or 13(g).
Is this position above 5% of SMTI's outstanding shares?
No. The filing states the reporting persons own 5 percent or less of the class, and the disclosed share count represents a de minimis percentage of the reported outstanding shares.
Which entities are named as reporting persons in the Schedule 13G/A?
The reporting persons are Baird Trust Company, Baird Financial Corporation, and Baird Financial Group, Inc., with addresses and citizenship shown on the cover pages provided in the filing.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
Sanara MedTech Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
79957L100
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
79957L100
1
Names of Reporting Persons
BAIRD TRUST Co
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
KENTUCKY
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
21,075.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
21,075.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
21,075.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.0 %
12
Type of Reporting Person (See Instructions)
BK
Comment for Type of Reporting Person: Items (6), (8), (9) and (11) reflect Common Stock ("Shares") that Baird Trust Company ("BTC") may be deemed to beneficially own within the meaning of Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the "Act"), by virtue of the investment discretion or voting authority granted to it by its clients over such Shares.
SCHEDULE 13G
CUSIP Number(s):
79957L100
1
Names of Reporting Persons
BAIRD FINANCIAL CORP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
WISCONSIN
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
21,075.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
21,075.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
21,075.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.0 %
12
Type of Reporting Person (See Instructions)
HC, CO
Comment for Type of Reporting Person: Items (6), (8), (9) and (11) consist of Shares held by Baird Trust Company.
SCHEDULE 13G
CUSIP Number(s):
79957L100
1
Names of Reporting Persons
Baird Financial Group, Inc.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
WISCONSIN
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
21,075.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
21,075.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
21,075.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.0 %
12
Type of Reporting Person (See Instructions)
HC, CO
Comment for Type of Reporting Person: Items (6), (8), (9) and (11) consist of Shares held by Baird Trust Company.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Sanara MedTech Inc.
(b)
Address of issuer's principal executive offices:
1200 SUMMIT AVE, SUITE 414, FORT WORTH, TEXAS, 76102.
Item 2.
(a)
Name of person filing:
(1) Baird Trust Company ("BTC")
(2) Baird Financial Corporation ("BFC")
(3) Baird Financial Group, Inc. ("BFG")
(b)
Address or principal business office or, if none, residence:
The address of the principal business office of BTC is:
500 West Jefferson Street, Suite 2600
Louisville, Kentucky 40202
The address of the principal business office of each of BFC and BFG is:
777 East Wisconsin Avenue
Milwaukee, Wisconsin 53202
(c)
Citizenship:
BTC is a Kentucky corporation and BFC and BFG are Wisconsin corporations.
(d)
Title of class of securities:
Common Stock
(e)
CUSIP No.:
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
See the responses to Item (9) on the foregoing cover pages.
This Schedule includes those securities beneficially owned by, or deemed beneficially owned by, BTC, BFC, and BFG (collectively, "BTC Reporting Units") that have been aggregated together in accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release") for purposes of filing this Schedule. This Schedule does not include securities, if any, beneficially owned by, or deemed beneficially owned by, BTC, BFC or BFG or their respective subsidiaries or affiliates that has been disaggregated from that of the BTC Reporting Units in accordance with the Release. In accordance with Rule 13d-4 of the Act, the Reporting Persons expressly declare that the filing of this Schedule shall not be construed as an admission that a Reporting Person is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any securities covered by this Schedule.
(b)
Percent of class:
See the responses to Item (11) on the foregoing cover pages. The percentage was calculated based upon 9,167,040 Shares of Common Stock outstanding at March 20, 2026 as reported by the Issuer in its Annual Report on Form 10-K for the year ended December 31, 2025.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See the responses to Item (5) on the foregoing cover pages.
(ii) Shared power to vote or to direct the vote:
See the responses to Item (6) on the foregoing cover pages.
(iii) Sole power to dispose or to direct the disposition of:
See the responses to Item (7) on the foregoing cover pages.
(iv) Shared power to dispose or to direct the disposition of:
See the responses to Item (8) on the foregoing cover pages.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See the response to Item 3 above. BTC is owned directly by BFC. BFC is, in turn, owned by BFG, which is the ultimate parent company of BTC.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
